Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors
Vijay Kumar Bhardwaj et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses
Rajanish Giri et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic
Eric Duverger et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases
Kathryn M. Kingsmore et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease
Tien Huynh et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial
Berta Grau-Pujol et al.
TRIALS (2020)
Is hydroxychloroquine beneficial for COVID-19 patients?
Xing Li et al.
CELL DEATH & DISEASE (2020)
Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies
Nabajyoti Baildya et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS) Protocol for a Pragmatic, Open-Label, Active Comparator Trial
Samuel M. Brown et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Structure and interactions of RecA: plasticity revealed by molecular dynamics simulations
Anu V. Chandran et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease
Ankur Kumar et al.
ACS OMEGA (2018)
Physical properties of the HIV-1 capsid from all-atom molecular dynamics simulations
Juan R. Perilla et al.
NATURE COMMUNICATIONS (2017)
Molecular dynamics simulations of large macromolecular complexes
Juan R. Perilla et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)
Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
Li-Fong Wang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
K. D. Rainsford et al.
INFLAMMOPHARMACOLOGY (2015)
Hydroxychloroquine: From Malaria to Autoimmunity
Ilan Ben-Zvi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Virus Capsid Dissolution Studied by Microsecond Molecular Dynamics Simulations
Daniel S. D. Larsson et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Long-timescale molecular dynamics simulations of protein structure and function
John L. Klepeis et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2009)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
New insights into the antiviral effects of chloroquine
A Savarino et al.
LANCET INFECTIOUS DISEASES (2006)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity
F Romanelli et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
The ability of chloroquine to prevent Tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity
F Rayne et al.
JOURNAL OF VIROLOGY (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Share Paper
